Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Website Related Posts Completes Two Pools Gold Acquisition October 17, 2025 Don Durrett: Gold, Silver Miners to Rip Even Higher, Here’s When to Buy October 17, 2025 Strategic Entry into Australian Gas Infrastructure Sector October 17, 2025